News
A mere week after getting shamed over its resurfaced "unsexiest women" countdown, Maxim is under fire yet again for another ...
4don MSN
Eric Maxim Choupo-Moting scores twice in second half to rally Red Bulls past Real Salt Lake 2-1
HARRISON, N.J. (AP) — Eric Maxim Choupo-Moting scored early in the second half and again on a penalty kick late in stoppage ...
More like “Unsexy and the City.” Netizens are ripping on a controversial 18-year-old Maxim article that listed the most ...
5h
LouderSound on MSNDream Theater hook up with Z2 comics for special Parasomnia graphic novel release
Reunited US prog metallers Dream Theater have released their new Parasomnia: The Graphic Album in various formats ...
22h
Fintel on MSNMaxim Group Downgrades Star Equity Holdings (STRR)
Fintel reports that on August 14, 2025, Maxim Group downgraded their outlook for Star Equity Holdings (NasdaqGM:STRR) from Buy to Hold. Analyst Price Forecast Suggests 295.89% Upside As of August 6, ...
Within the anime community, there is a large portrayal of classic entertainment genres: fantasy, sci-fi, romance, and action.
12h
Sporting News on MSNBrighton vs. Fulham lineups: Predicted starting XI, team news, injury latest with Carlos Baleba, Man United talks overshadowing Premier League opener
Predicted lineups, injury news, and updates for Brighton vs. Fulham as transfer talks and key absences overshadow the Premier ...
Discover 10 striking photos of Anna Paulina Luna, tracing her path from Maxim model to Florida's first Mexican-American ...
Semler Scientific, Inc. (NASDAQ: SMLR) is one of the best medical device stocks to buy according to analysts . Analyst ...
Eight weeks from today, the New York Islanders will be battling the Pittsburgh Penguins at PPG Paints Arena to kick off the ...
Eric Maxim Choupo-Moting leads the New York Red Bulls into a matchup with the Philadelphia Union after scoring two goals against Real Salt Lake.
5h
TipRanks on MSNReviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
Maxim analyst Jason McCarthy lowered the firm’s price target on Reviva Pharmaceuticals (RVPH) to $2 from $5 and keeps a Buy rating on the shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results